dr. A. Wunderink

No picture available
E-mail:
a.wunderink umcg.nl

Research

  1. 2020
  2. 2019
  3. 2018
  4. 2017
  5. Ising, H. K., Lokkerbol, J., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Kraan, T., ... van der Gaag, M. (2017). Cost-effectiveness of Cognitive Behavior Therapy for Preventing First-episode Psychosis in People with Ultra-High Risk. Journal of Mental Health Policy and Economics, 20, S17-S17.
  6. 2016
  7. Ising, H., Smit, F., Ruhrmann, S., Veling, W., Rietdijk, J., Dragt, S., ... Van Der Gaag, M. (2016). Improving outcome with CBTuhr: Costeffectiveness and profiling after 4-years. 76. https://doi.org/10.1111/eip.12396
  8. Ising, H., Smit, F., Ruhrmann, S., Veling, W., Rietdijk, J., Dragt, S., ... van der Gaag, M. (2016). Improving Outcome with CBTuhr: Cost-effectiveness and Profiling After 4-Years. Early intervention in psychiatry, 10, 76-76.
  9. Alvarez-Jimenez, M., O'Donoghue, B., Thompson, A., Gleeson, J. F., Bendall, S., Gonzalez-Blanch, C., ... McGorry, P. D. (2016). Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era. Cns Drugs, 30(5), 357-368. https://doi.org/10.1007/s40263-016-0331-x
  10. 2015
  11. 2014
  12. 2013
  13. 2012
  14. Ising, H., Veling, W., Loewy, R., Rietveld, M., Rietdijk, J., Dragt, S., ... Van Der Gaag, M. (2012). Psychosis risk screening in routine mental health care. 1. https://doi.org/10.1111/j.1751-7893.2012.00392.x
  15. Velthorst, E., Nieman, D. H., Veling, W., Klaassen, R. M., Dragt, S., Rietdijk, J., ... Van Der Gaag, M. (2012). Ethnicity and baseline symptomatology in patients with an At Risk Mental State for psychosis. Psychological Medicine, 42(2), 247-256. https://doi.org/10.1017/S0033291711001486
Previous 1 2 Next

ID: 226476